BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Unprecedented momentum is building in 2025:- Kriya Therapeutic
 s advancing through preclinical development- Opus Genetics and SpliceBio 
 entering their early trials- Ocugen\, 4D Molecular Therapeutics\, and Abb
 Vie racing towards BLA approval\n\nThis surge creates an urgent demand to
  mitigate critical bottlenecks like endpoints\, funding\, delivery\, and 
 more. The 6th Gene Therapy for Ophthalmic Disorders Summit returns to Ral
 eigh\, North Carolina\, as the leading industry-specific event uniting bi
 opharma scientists and strategists to tackle these challenges head-on. Jo
 in us to unlock the next breakthrough beyond Luxturna and accelerate your
  therapy to patients.\n\nWhat is the 6th Gene Therapy for Ophthalmic Diso
 rders Summit About?\n\nWith vision loss progressing rapidly in many eye d
 iseases\, and irreversible damage threatening patients with slower-onset 
 conditions\, gene therapies represent a critical one-time intervention to
  preserve sight.\n\nThe 6th Gene Therapy for Ophthalmic Disorders Summit 
 brings together the latest breakthroughs driving this urgent field forwar
 d. This year's agenda features exclusive preclinical data from emerging l
 eaders such as Opus Genetics\, Coave Therapeutics\, and Axovia Therapeuti
 cs\, alongside 2025 clinical updates from Ocugen\, Adverum Biotechnologie
 s\, and Beacon Therapeutics.\n\nDon't miss groundbreaking data reveals an
 d our dedicated focus on securing funding\, advancing AAV delivery\, and 
 optimizing patient retention strategies - factors that are revolutionizin
 g trial outcomes and shaping regulatory success\n\nDate and Time: Tuesday
 \, 02 December 2025 at 08:00 - Thursday\, 04 December 2025 at 17:00\n
DTEND:20251204T170000
DTSTAMP:20260512T214934Z
DTSTART:20251202T080000
LOCATION:DoubleTree by Hilton Raleigh Midtown\, 2805 Highwoods Boulevard\,
  Raleigh\, North Carolina\, 27604\,
SEQUENCE:0
SUMMARY:Unprecedented momentum is building in 2025:- Kriya Therapeutics ad
 vancing through preclinical development- Opus Genetics and SpliceBio ente
 ring the...
UID:8a4a899e-40e7-4947-9073-08f33dcfa892
END:VEVENT
END:VCALENDAR